CoVac-1 COVID Vaccine May Provide Protection for Cancer Patients with B-cell Deficiencies
The novel CoVac-1 COVID vaccine induced T-cell immune responses in 93% of patients with B-cell deficiencies, including many patients with leukemia and lymphoma.